Literature DB >> 26223361

Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphoma.

Toby A Eyre1, Richard Salisbury2, David W Eyre3, Caroline Watson2, Graham P Collins2, Chris S Hatton2.   

Abstract

Entities:  

Keywords:  DLBCL; R-CHOP; dose intensity; elderly

Mesh：

Substances：

Year:  2015        PMID： 26223361     DOI： 10.1111/bjh.13619

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review.

Authors:  Edward J Bataillard; Chan Yoon Cheah; Matthew J Maurer; Arushi Khurana; Toby A Eyre; Tarec Christoffer El-Galaly
Journal:  Blood Adv       Date:  2021-05-11

2.  Predictors of Chemotherapy Related Toxicities in Elderly Lymphoma Patients: Experience from a Tertiary Cancer Centre.

Authors:  Sourav Mishra; Venkatraman Radhakrishnan; Prasanth Ganesan; Rejiv Rajendranath; Swaminathan Rajaraman; Trivadi S Ganesan; Tenali Gnana Sagar
Journal:  Indian J Hematol Blood Transfus       Date:  2017-02-25       Impact factor: 0.900

3.  The average relative dose intensity of R-CHOP is an independent factor determining favorable overall survival in diffuse large B-cell lymphoma patients.

Authors:  Monika Długosz-Danecka; Sebastian Szmit; Tomasz Ogórka; Aleksander B Skotnicki; Wojciech Jurczak
Journal:  Cancer Med       Date:  2019-02-10       Impact factor: 4.452

Review 4.  Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma.

Authors:  Murali Kesavan; Toby A Eyre; Graham P Collins
Journal:  Curr Hematol Malig Rep       Date:  2019-08       Impact factor: 3.952

5.  Cure rate in the elderly patients with diffuse large B cell lymphoma deteriorates after the age of 80-results from a single-center survey.

Authors:  Felix Freudenberger; Anke Ohler; Matthias Theobald; Georg Hess
Journal:  Ann Hematol       Date:  2021-02-25       Impact factor: 3.673

6.  A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL.

Authors:  Kathrine T Isaksen; Maria Adele Mastroianni; Marit Rinde; Leiv Sindre Rusten; Dlawer Abdulla Barzenje; Lloyd Frode Ramslien; Marit Slaaen; Marianne Brenn Jerm; Erlend B Smeland; Siri Rostoft; Knut Liestøl; Marianne Brodtkorb; Harald Holte
Journal:  Blood Adv       Date:  2021-11-23

7.  Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England.

Authors:  L Hounsome; T A Eyre; R Ireland; A Hodson; R Walewska; K Ardeshna; S Chaganti; P McKay; A Davies; C P Fox; N Kalakonda; P A Fields
Journal:  Br J Cancer       Date:  2021-10-05       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.